Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF chemotherapy for locally advanced or metastatic penile squamous cell carcinoma
ISRCTN78108737Phase 2Completed
- Sponsor
- Sponsor not yet defined (UK)
- Start
- Jun 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin and fluorouracil in penile squamous cell carcinoma (PSCC), sponsored by Sponsor not yet defined (UK). Primary endpoint: Overall response rate. Started Jun 2008; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on ISRCTN78108737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN78108737.